Cyclo Therapeutics Inc (CYTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,541 | 610 | 1,271 | 1,343 | 1,331 |
| Receivables | 91 | 48 | 57 | 94 | 102 |
| Inventories | 408 | 453 | 471 | 474 | 473 |
| Other current assets | 81 | 101 | 97 | 55 | 78 |
| TOTAL | $2,121 | $1,212 | $1,896 | $1,965 | $1,983 |
| Non-Current Assets | |||||
| PPE Net | 22 | 25 | 26 | 27 | 26 |
| Other Non-Current Assets | 149 | 164 | 167 | 177 | 186 |
| TOTAL | $172 | $189 | $193 | $205 | $212 |
| Total Assets | $2,293 | $1,401 | $2,089 | $2,170 | $2,195 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,289 | 993 | 943 | 545 | 566 |
| Other current liabilities | N/A | 75 | N/A | 585 | N/A |
| TOTAL | $1,289 | $1,068 | $943 | $1,130 | $566 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,289 | $1,068 | $943 | $1,130 | $566 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 877 | 735 | 735 | 731 | 731 |
| Common Shares | 9 | 7 | 7 | 7 | 7 |
| Retained earnings | -15,435 | -14,146 | -13,333 | -11,949 | -11,315 |
| TOTAL | $1,003 | $333 | $1,146 | $1,040 | $1,629 |
| Total Liabilities And Equity | $2,292 | $1,401 | $2,089 | $2,170 | $2,195 |